Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002344237 | SCV002646614 | likely pathogenic | Inborn genetic diseases | 2018-11-29 | criteria provided, single submitter | clinical testing | The c.5137-2A>C intronic variant results from an A to C substitution two nucleotides upstream from coding exon 34 in the CACNA1A gene. This nucleotide position is highly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to abolish the native splice acceptor site; however, direct evidence is unavailable. Based on the majority of available evidence to date, this variant is likely to be pathogenic. |